Expanded access to psychedelic treatments: comparing American and Canadian policies.
Gen Psychiatr – February 19, 2025
Source: PubMed Central
Summary
Access to promising psychedelic treatments isn't uniform globally. American and Canadian policies differ significantly on patient access to unapproved psychedelic therapies. Regulatory analysis shows Canada's compassionate use programs offer clearer, more streamlined patient access to these emerging medicines than America's evolving system. This impacts how individuals receive innovative care.
Abstract
Expanded access to psychedelic treatments: comparing American and Canadian policies.